Jiří Michálek

Jiří Michálek

Auto-generated profile, based on publicly available information

Jiří Michálek

Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
JSJakub Sirc
Jakub Sirc
RHRadka Hobzová
Radka Hobzová
NKNina Kostina
Nina Kostina
MMMarcela Munzarová
Marcela Munzarová
MJMartina Juklíčková
Martina Juklíčková
JMJiří Michálek
Jiří Michálek
Biomedical applications such as wound dressing for skin regeneration, stem cell transplantation, or drug delivery require special demands on the three‐dimensional porous scaffolds. Besides the biocompatibility and mechanical properties, the morphology is the most important attribute of the scaffold. Specific surface area, volume, and size of the pores have considerable effect on cell adhesion, growth, and proliferation. In the case of incorporated biologically active substances, their release is also influenced by the internal structure of nanofibers. Although many scientific papers are focused on the preparation of nanofibers and evaluation of biological tests, the morphological characterization was described just briefly as service methods. The aim of this paper is to summarize the methods applicable for morphological characterization of nanofibers and supplement it by the results of our research. Needleless electrospinning technique was used to prepare nanofibers from polylactide, poly(ε‐caprolactone), gelatin, and polyamide. Scanning electron microscopy was used to evaluate the fiber diameters and to reveal eventual artifacts in the nanofibrous structure. Nitrogen adsorption/desorption measurements were employed to measure the specific surface areas. Mercury porosimetry was used to determine total porosities and compare pore size distributions of the prepared samples.

6 January 2010 in Stem Cells and Development
Verified
Journal Article
Closed access
Aleš HejčlAleš Hejčl
Aleš Hejčl
JŠJiří Šedý
Jiří Šedý
MKMiroslava Kapcalová
Miroslava Kapcalová
DTDavid Arboleda Toro
David Arboleda Toro
TATakashi Amemori
Takashi Amemori
ESEva Syková
Eva Syková
Chronic spinal cord injury (SCI) is characterized by tissue loss and a stable functional deficit. While several experimental therapies have proven to be partly successful for the treatment of acute SCI, treatment of chronic SCI is still challenging. We studied whether we can bridge a chronic spinal cord lesion by implantation of our newly developed hydrogel based on 2-hydroxypropyl methacrylamide, either alone or seeded with mesenchymal stem cells (MSCs), and whether this treatment leads to functional improvement. A balloon-induced compression lesion was performed in adult 2-month-old male Wistar rats. Five weeks after injury, HPMA-RGD hydrogels [ N -(2-hydroxypropyl)-methacrylamide with attached amino acid sequences—Arg-Gly-Asp] were implanted into the lesion, either with or without seeded MSCs. Animals with chronic SCI served as controls. The animals were behaviorally tested using the Basso–Beattie–Breshnahan (BBB) (motor) and plantar (sensory) tests once a week for 6 months. Behavioral analysis showed a statistically significant improvement in rats with combined treatment, hydrogel and MSCs, compared with the control group ( P < 0.05). Although a tendency toward improvement was found in rats treated with hydrogel only, this was not significant. Subsequently, the animals were sacrificed 6 months after SCI, and the spinal cord lesions evaluated histologically. The combined therapy (hydrogel with MSCs) prevented tissue atrophy ( P < 0.05), and the hydrogels were infiltrated with axons myelinated with Schwann cells. Blood vessels and astrocytes also grew inside the implant. MSCs were present in the hydrogels even 5 months after implantation. We conclude that 5 weeks after injury, HPMA-RGD hydrogels seeded with MSCs can successfully bridge a spinal cord cavity and provide a scaffold for tissue regeneration. This treatment leads to functional improvement even in chronic SCI.

14 February 2012 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
MDMichal Dubsky
Michal Dubsky
SKSarka Kubinova
Sarka Kubinova
JŠJakub Širc
Jakub Širc
LVLuděk Voska
Luděk Voska
RZRobert Zajíček
Robert Zajíček
ESEva Syková
Eva Syková

1 January 2008 in Physiological Research
Verified
Journal Article
Closed access
AHA Hejčl
A Hejčl
PLP Lesný
P Lesný
MPM Přádný
M Přádný
JMJ Michálek
J Michálek
Pavla JendelovaPavla Jendelova
Pavla Jendelova
ESE Syková
E Syková
Spinal cord injury results in a permanent neurological deficit due to tissue damage. Such a lesion is a barrier for "communication" between the brain and peripheral tissues, effectors as well as receptors. One of the primary goals of tissue engineering is to bridge the spinal cord injury and re-establish the damaged connections. Hydrogels are biocompatible implants used in spinal cord injury repair. They can create a permissive environment and bridge the lesion cavities by providing a scaffold for the regeneration of neurons and their axons, glia and other tissue elements. The advantage of using artificial materials is the possibility to modify their physical and chemical properties in order to develop the best implant suitable for spinal cord injury repair. As a result, several types of hydrogels have been tested in experimental studies so far. We review our work that has been done during the last 5 years with various types of hydrogels and their applications in experimental spinal cord injury repair.

1 April 2013 in Carbohydrate Polymers
Verified
Journal Article
Closed access
Maria Valentina DinuMaria Valentina Dinu
Maria Valentina Dinu
MPMartin Přádný
Martin Přádný
EDEcaterina Stela Dragan
Ecaterina Stela Dragan
JMJiří Michálek
Jiří Michálek

25 September 2015 in Beilstein Journal of Nanotechnology
Verified
Journal Article
Open access
PDF file
JHJakub Hrib
Jakub Hrib
JSJakub Sirc
Jakub Sirc
RHRadka Hobzova
Radka Hobzova
ZHZuzana Hampejsova
Zuzana Hampejsova
ZBZuzana Bosakova
Zuzana Bosakova
JMJiri Michalek
Jiri Michalek
Nanofibers were prepared from polycaprolactone, polylactide and polyvinyl alcohol using NanospiderTM technology. Polyethylene glycols with molecular weights of 2 000, 6 000, 10 000 and 20 000 g/mol, which can be used to moderate the release profile of incorporated pharmacologically active compounds, served as model molecules. They were terminated by aromatic isocyanate and incorporated into the nanofibers. The release of these molecules into an aqueous environment was investigated. The influences of the molecular length and chemical composition of the nanofibers on the release rate and the amount of released polyethylene glycols were evaluated. Longer molecules released faster, as evidenced by a significantly higher amount of released molecules after 72 hours. However, the influence of the chemical composition of nanofibers was even more distinct – the highest amount of polyethylene glycol molecules released from polyvinyl alcohol nanofibers, the lowest amount from polylactide nanofibers.